Two Sigma Investments, LP In8 Bio, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.95 - $1.69 $758 - $1,348
-798 Reduced 1.89%
41,528 $49,000
Q4 2023

Feb 14, 2024
BUY
$0.69 - $2.34 $29,204 - $99,042
42,326 New
42,326 $58,000
Q2 2023

Aug 14, 2023
BUY
$1.05 - $3.24 $19,098 - $58,932
18,189 New
18,189 $28,000

Others Institutions Holding INAB

# of Institutions
27
Shares Held
7.62M
Call Options Held
0
Put Options Held
0
View Full List

About IN8BIO, INC.

INAB Quotes by TradingView
  • Ticker INAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,502,200
  • Market Cap $6.13M
  • Description
  • IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...
More about INAB
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email